SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 118 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 3.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,329,439 | -80.2% | 1,635,514 | -69.6% | 0.04% | -79.5% |
| Q2 2023 | $32,012,906 | +53.0% | 5,371,293 | -16.1% | 0.22% | +45.7% |
| Q1 2023 | $20,928,000 | -17.2% | 6,400,000 | 0.0% | 0.15% | -21.8% |
| Q4 2022 | $25,280,000 | +65733.3% | 6,400,000 | 0.0% | 0.19% | -40.4% |
| Q3 2022 | $38,400 | -99.9% | 6,400,000 | 0.0% | 0.32% | -6.9% |
| Q2 2022 | $41,152,000 | +20.6% | 6,400,000 | +54.9% | 0.35% | +67.3% |
| Q1 2022 | $34,124,000 | -46.6% | 4,131,249 | 0.0% | 0.21% | -39.4% |
| Q4 2021 | $63,952,000 | -31.3% | 4,131,249 | 0.0% | 0.34% | -35.5% |
| Q3 2021 | $93,036,000 | +5.0% | 4,131,249 | -8.4% | 0.53% | -0.4% |
| Q2 2021 | $88,629,000 | -35.9% | 4,508,111 | +9.1% | 0.53% | -40.0% |
| Q1 2021 | $138,273,000 | – | 4,131,249 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |